Long noncoding RNAs: a novel prognostic marker in older patients with acute leukemia

A new study led by researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute describes a novel marker that might help doctors choose the least toxic, most effective treatment for many older patients with acute myeloid leukemia. The researchers investigated patterns of molecules called long noncoding RNAs (lncRNAs). The researchers examined the abundance, or expression, of lncRNAs in patients who were 60 years and older and who had cytogenetically normal AML. Read more here.